Report #2832647

Received Mar 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: FL
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (ENGERIX-B)	GLAXOSMITHKLINE BIOLOGICALS	4	MD9SL	—

Symptoms (1)

Extra dose administered

Symptom narrative

received 4 doses of Engerix-B inadvertently; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a female patient who received HBV (Engerix B) (batch number MD9SL, expiry date 08-DEC-2026) for prophylaxis. Previously administered products included Engerix b (received first dose of Engerix b on an unknown date), Engerix b (received second dose of Engerix b on an unknown date) and Engerix b (received third dose of Engerix b on an unknown date). On an unknown date, the patient received the 4th dose of Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced extra dose administered (Verbatim: received 4 doses of Engerix-B inadvertently). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date: 13-MAR-2025 The pharmacist reports a patient received 4 doses of Engerix b inadvertently which led to extra dose administered.